45 results
8-K
EX-10.1
ALKS
Alkermes plc
31 May 24
Departure of Directors or Certain Officers
4:05pm
, drug development or commercialization milestones, collaboration milestones, operational measures including production capacity and capability, hiring
8-K
EX-10.3
e43yfpa9vb06hi01u 3d
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
EX-2.1
h6f9h3
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
EX-10.4
cd7pc5vg1cbf6spn
15 Nov 23
Alkermes Completes Separation of Oncology Business
7:05am
8-K
EX-10.1
a5t k611xg
6 Jul 23
Departure of Directors or Certain Officers
8:05am
DEFC14A
6cfr b9rn6e6z6w
25 May 23
Proxy in contested solicitation
4:03pm
PRER14A
dkkg6bg24b
19 May 23
Preliminary revised proxy
5:23pm
PREC14A
hp0tamsaev4l4
8 May 23
Preliminary proxy with contested solicitation
4:34pm
8-K
EX-10.1
xvegvdjqehxz3
7 Jul 22
Alkermes Announces Results of Annual General Meeting of Shareholders
5:20pm
DEFC14A
o5soebq9zlc7un0qw
6 Jun 22
Proxy in contested solicitation
5:29pm
PREC14A
18my9t1g
26 May 22
Preliminary proxy with contested solicitation
5:29pm
8-K
EX-10.1
4yhlaujfpg spc1x
14 Jun 21
Departure of Directors or Certain Officers
4:23pm